AbbVie ABBV Cash Flow Statement (2012-2026)

NYSE ABBV
$252.76 +1.85 (+0.74%)
As of: Sep 10, 2026 · 2:19 PM EDT
Reported Financials

AbbVie Quarterly Cash Flow Statement

Periods 58 quarters
Latest Jun 2026

AbbVie reported cash from operations of $3.44B and free cash flow of $3.11B for the quarter ended Jun 2026, down 33.3% year over year. This cash flow statement covers 58 quarters of results from Mar 2012 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
3.18B4.04B4.49B0.93B3.95B2.47B-0.10B2.03B1.78B0.82B1.37B1.37B1.56B-0.02B1.29B0.94B0.19B1.81B0.70B3.62B
Share-based CompensationStock Comp.
0.14B0.13B0.31B0.11B0.13B0.13B0.31B0.18B0.13B0.12B0.35B0.22B0.18B0.16B0.41B0.18B0.21B0.16B0.44B0.17B
Deferred Taxes
-0.03B-0.74B-0.19B-0.60B-0.62B-0.52B-0.27B-0.37B-0.86B-1.39B-0.39B-0.02B-0.28B-0.77B-0.03B-0.27B0.19B-0.39B0.14B-0.20B
Gains from Investment SecuritiesGains Investment
0.10B0.23B-0.75B1.61B-0.21B2.11B1.87B1.55B0.01B1.70B0.66B1.48B1.36B0.28B1.52B2.79B0.78B1.41B2.39B1.52B
Asset Writedowns and ImpairmentWritedown
0.77B0.71B2.11B1.41B4.48B
Cash from OperationsCash from Ops.
7.93B5.08B4.91B5.00B7.60B7.43B4.19B6.32B7.57B4.75B4.04B2.27B5.45B7.05B1.64B5.15B7.02B5.22B3.83B3.44B
Change in Working Capital
Change in ReceivablesChange Receivables
-0.59B0.75B0.79B0.61B-0.36B0.42B0.20B0.08B-0.00B-0.34B0.70B-0.18B-0.34B-0.39B1.48B0.02B0.16B-0.16B-0.09B1.37B
Change in InventoryChange Inventory
-0.22B0.11B0.39B0.11B0.02B0.17B0.18B0.27B0.06B-0.10B0.07B0.05B0.06B0.13B0.15B0.06B-0.00B0.03B0.18B0.14B
Change in Accured ExpensesChange Accured Exp.
1.15B0.27B-0.26B-0.19B0.94B1.28B-0.45B1.57B2.54B0.18B0.36B-1.70B0.27B1.25B-0.70B0.52B1.73B-0.60B-1.59B1.20B
Change in TaxesChange Taxes
-0.07B-0.66B0.44B-0.55B0.29B0.36B0.19B-1.12B0.03B0.41B0.38B-1.83B0.05B-1.80B0.38B-1.38B-0.41B0.65B-0.08B-2.22B
Investing Activities
Capital ExpendituresCapex
0.22B0.19B0.16B0.14B0.18B0.21B0.17B0.18B0.22B0.20B0.19B0.24B0.25B0.29B0.23B0.27B0.38B0.33B0.27B0.32B
Acquisitions
0.53B9.20B8.29B0.20B
Change in Acquisitions & DivestmentsChange Acquisitions
0.02B0.01B0.01B0.04B1.41B0.07B0.02B0.01B0.01B0.01B0.01B0.00B0.51B0.04B0.03B0.01B0.00B0.03B
Cash from Investing ActivitiesCash from Investing
-0.61B-1.15B-1.59B0.13B1.29B-0.45B-0.50B-0.34B-0.37B-0.80B-9.59B-1.10B-8.26B-1.87B-0.73B-1.18B-3.26B-1.46B-0.57B-1.20B
Financing Activities
Other financing activitiesOther financing
0.03B0.07B0.13B0.07B0.01B0.05B0.07B0.05B0.04B0.03B0.13B0.01B0.07B0.01B0.07B0.00B0.05B0.05B0.00B0.03B
Cash from Financing ActivitiesCash from Financing
-3.64B-6.34B-6.97B-2.68B-5.52B-9.63B-6.19B-3.92B-2.66B-4.45B10.82B-6.10B-3.07B-6.86B-1.26B-2.71B-4.59B-4.17B0.92B-5.05B
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
Dividend Payments
Dividends Paid - CommonDiv. Paid (Common)
2.31B2.31B2.53B2.51B2.50B2.51B2.66B2.62B2.63B2.63B2.77B2.75B2.75B2.75B2.92B2.91B2.91B2.91B3.09B3.07B
Additional items
Exchange Rate EffectFX Effect
-0.04B-0.03B0.01B-0.03B-0.06B0.02B0.01B-0.01B-0.02B0.02B-0.02B-0.01B0.01B-0.05B0.01B0.03B-0.01B0.01B-0.01B-0.01B
Change in Cash
3.64B-2.44B-3.65B2.42B3.31B-2.63B-2.49B2.05B4.53B-0.47B5.25B-4.94B-5.87B-1.73B-0.35B1.29B-0.84B-0.40B4.16B-2.82B
Free Cash FlowFCF
7.72B4.89B4.75B4.86B7.42B7.21B4.02B6.14B7.36B4.55B3.85B2.03B5.20B6.76B1.40B4.88B6.64B4.89B3.56B3.11B
Net Cash FlowNCF
3.68B-2.41B-3.65B2.46B3.37B-2.65B-2.50B2.06B4.54B-0.50B5.27B-4.93B-5.88B-1.69B-0.36B1.26B-0.83B-0.41B4.17B-2.81B